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CASE REPORT
Introduction
Numerous drops are commer-cially available for relief   
of  ocular afflictions such as  
allergies, dry eye, contact lens  
related discomfort, glaucoma and 
ocular infections. Containers,  
similar in shape and size to eye 
drops are also available for other 
purposes, one being nail adhesive/
glue. Cyanoacrylate1, a synthetic 
adhesive found in nail glue, can 
cause strong adhesion of  tissues 
with which it comes in contact, 
such as the eyelids or conjunc-
tiva. Due to its inherent adhesive 
properties, cyanoacrylate has been 
reported to be useful in external 
ophthalmic surgical procedures 
such as sealing corneal perfora-
tions and tarsorraphy.2, 3 Due to its 
rapid polymerization with water, 
a minimal amount is applied to a 
dried surface for tissue adhesion.1
Similarities in packaging of  
nail glue to ophthalmic products 
can lead to patient confusion and 
potentially harmful ocular trauma. 
The American Academy of  Oph-
thalmology (AAO) initiated, in 
1996, a colour coding system for 
the caps and labels of  different 
new classes of  ophthalmic solu-
tions to minimize errors.4 Table 
1 summarizes the colour coding 
system which is updated regularly 
as classes of  drugs are introduced. 
Conjunctival trauma following inadvertent use of nail glue  
containing cyanoacrylate, leads to patient education pamphlet
Similarities in packaging, bottle size and cap 
design of nail glue with ophthalmic products 
has led to patient confusion and inadvertent 
use of nail glue causing ocular trauma both 
in the adult and pediatric population. Despite 
efforts and pressures from several reports, 
little has been achieved with respect to 
unregulated health and beauty products. 
This case report describes a conjunctival 
trauma caused by inadvertent use of nail glue 
and highlights the importance of patient 
education. Basic precautions, such as reading 
the label of ophthalmic medication under 
proper lighting and with adequate correction 
coupled with the segregation of ophthalmic 
products from others in the medicine cabinet, 
could prevent ocular injury. To this end, an 
awareness pamphlet has been created to 
bring further awareness to this issue.




Colour scheme system for ophthalmic solution caps
Colour Description Pantone colour
Tan Anti-infectives (antibiotics, antivirals, antifungals) 467
Pink Anti-inflammatories or steroids  197
Grey Non-steroidal anti-inflammatories (NSAID) 4
Red Mydriatics/cycloplegics 1797
Green Miotics 348
Yellow Beta-blockers Yellow C
Blue Beta-blocker combinations 281
Purple Adrenergic agonist 2583
Orange Carbonic anhydrase inhibitors 1585
Turquoise Prostaglandin analogues 326
Source: www.aao.org
BY ettY Bitton, oD, Msc,  FAAo
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Similarities in size and shape of  
ophthalmic containers have lead to 
errors both by patients and medi-
cal personnel. Other health and 
beauty products, such as nail glue 
or superglue, with similar sizing to 
eye drops, have also been instilled 
inadvertently, both in adults and 
children. 5-12 Thankfully, since cya-
noacrylate is synthetic and nonbio-
degradable, spontaneous rejection 
of  the glue occurs with relatively 
favorable prognosis dependent on 
the tissue affected.13, 14
Patient education can be the 
first line of  defense in preventing 
potential harmful ocular trauma. 
Simple safeguards can be empha-
sized to patients, such as separation 
of  all ophthalmic products from 
other health items as well as keep-
ing all medications away from chil-
dren. This case report highlights 
the preventative measures needed 
to avoid ocular injuries by inad-
vertent instillation of  non-ocular 
health and beauty products, such as 
nail adhesive for artificial nails. As a 
result of  this case report, a patient 
education pamphlet was designed  
 
to inform patients on how to 
prevent injuries in the home due to 
similarities in product appearance.
Case report
A 64 year old female was search-
ing for eye drops to relieve some 
ocular discomfort after a late night 
out following removal of  her soft 
contact lenses (CL). Confused by 
uncorrected vision, fatigue and 
similar looking containers in the 
dimly lit washroom, the patient 
inadvertently instilled nail adhe-
sive in her right eye instead of  the 
intended eye drops. The result-
ing severe burning and tearing 
provoked the patient to quickly 
blink and rinse her eye profusely. 
She reported that her lashes were 
stuck together for several minutes 
following the incident. The patient 
presented for consultation only 
36 hours after the incident and 
reported progressive improvement 
of  the condition, however the lids 
remained very swollen. 
Upon presentation, the patient’s 
symptoms included lid swelling 
of  the right eye with mild ocu-
lar discomfort. The patient had 
ceased CL wear and reported no 
visual disruption. Presenting best 
corrected vision were good (OD 
6/6-2, OS 6/6-1, OU 6/6). Slit lamp 
examination (SLE) of  the right  
eye revealed a mild periorbital 
lid edema (Figure 1), a moder-
ate (grade 2) bulbar conjunctival 
hyperemia (Figure 2) with a mild 
limbal congestion, a superior con-
junctival hyperemia and a 6 mm 
wide tissue trauma, grade 4 (zone 
1, 2, 3 and 4 as defined using the 
CCLRU grading scales)15 (Figure 
3). No foreign body was found un-
der the upper lid. The lashes, pal-
pebral margin, cornea and anterior 
 
Figure 1: Lid swelling associated with 
inadvertent instillation of  nail glue in  
the eye.
 
Figure 2: Limbal hyperemia associated with ocular irritation from nail glue instillation.
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chamber of  the right eye revealed 
no anomalies or staining with 
fluorescein. The left eye revealed 
no anomalies. A mild meibomian 
gland (MG) obstruction was noted 
in both eyes, but the record re-
vealed that this was a pre-existing 
condition. The remainder of  the 
ocular exam was unremarkable.
The clinical management 
included an ocular lavage of  the 
upper tarsus with a rinsing solution 
(Multipurpose Sensitive Eyes™, 
B+L) during the consultation and 
subsequent use of  unpreserved 
ocular lubricants (BION™ Tears, 
ALCON) qid for 48 hrs. The 
patient was instructed not to use 
make-up or contact lenses until the 
next follow-up visit.
At the 48 hour follow-up 
visit, (now four days post-trauma), 
symptoms were vastly improved. 
No stinging or burning was report-
ed and the patient reported that 
her affected eye “felt and looked” 
better. Best corrected acuities were 
OD/OS 6/6-1, OU 6/6. The SLE 
of  the right eye revealed minimal 
lid edema, slight bulbar conjunctival 
hyperemia. Figure 4 reveals the 
slowly regressing superior conjunc-
tival trauma (6 mm wide), grade 3 
(zone 2, 3). The lashes, palpebral 
margin, cornea, anterior chamber 
revealed no anomalies. Clinical 
management included continua-
tion of  unpreserved tear lubricants 
qid for 7 days, no CL wear and a 
follow-up in one week.
The patient was lost to follow-
up due to hip replacement surgery 
followed by bed rest and physio-
therapy sessions. She consulted 
four months later with vast im-
provement of  her ocular condi-
tion. The patient had reinitiated 
CL wear several weeks prior and 
had no associated symptoms. She 
also reported that she had separat-
ed her ophthalmic products from 
other products in her medicine 
cabinet. Her vision remained stable 
(OD 6/6, OS 6/6-1, OU 6/6) and 
a SLE revealed no anomalies in 
either eye (Figure 5) except for the 
mild preexisting MG obstruction. 
Clinical management included 
lubricating drops, (Systane™, 
ALCON) prn, to aid with tear film 
stability, which was a bit worse in 
the right eye (tear break up time-
TBUT OD 2-3 sec, OS 5 sec)  
and warm compresses and gland 
expression for the mild MG dys-
function. Routine follow ups at 
 
Figure 3: Conjunctival trauma related to unintentional use of  nail glue in the eye. The superficial layers were sloughed off  resulting in a 
large area (6mm wide) of  fluorescein uptake by zones 1-3 of  the palpebral conjunctiva. 
 
Figure 4: Regressing conjunctival trauma at the 48-hour follow up visit (4 days post 
trauma).
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annual visits were recommended.
The patient was asked to bring 
the eye drop and the nail adhe-
sive containers for comparison. 
Figure 6 shows the similarities in 
bottle size, shape and bell-shaped 
bottle cap, which were contribu-
tory factors, adding to the confu-
sion. Although the caps were of  
different colours, the uncorrected 
vision following CL removal, dim 
lighting of  the room and the tired 
state of  the patient compounded 
by the fact that the containers were 
side by side were all contributory 
to the confusion. Further evalua-
tion of  the eye drops revealed that 
in fact they were not intended for 
CL related relief, but were a topical 
anti-infective (antibiotic steroid) 
that was used for a previous eye 
infection and were past their expiry 
date. This revelation prompted a 
discussion with the patient about 
proper identification of  ophthal-
mic products and appropriate 
placement of  products in the 
medicine cabinet and the disposal 
of  expired medication.
Discussion 
The similarities in packaging of  
ophthalmic preparations and 
other beauty products, such as 
nail adhesive, have been the cause 
of  numerous unnecessary ocu-
lar trauma, reported both in the 
adult and pediatric population.5-11 
Despite efforts to bring awareness 
to this issue, similarities in product 
 
Figure 5: Resolved conjunctival trauma 4 months post trauma.
 
Figure 6: Similarities of  bottle size and caps between nail glue and an ophthalmic solution 
in (A) poor lighting conditions and (B) normal conditions.
 
Figure 7: Interchangeable caps and similar colouring can cause confusion between drops intended for (A) pupillary dilation and topical 
anesthetics or between (B) ocular lubricants and glaucoma medication.
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packaging continues to threaten 
patients’ safety.
Although colour coding the 
bottle caps has improved the iden-
tification of  ophthalmic products 
both for in-office use and home 
purposes, interchangeable caps can 
still lead to mistakes. For example, 
attention in the practitioner's office 
in recapping bottles intended for 
pupillary dilation is extremely im-
portant so as not to inadvertently 
dilate a patient at risk for angle 
closure. At home, interchangeable 
caps may lead to instillation of  tear 
lubricants or anti-infectives instead 
of  glaucoma medication. Figure 7 
demonstrates interchangeable caps 
between drops intended for papil-
lary dilation and topical anesthet-
ics and between ocular lubricants 
and glaucoma medication. In the 
latter case, the green cap looks well 
coupled with the ocular lubricant 
since the label has a similar colour.
Similarities in package appear-
ance amongst leading contact lens 
solutions can also lead to inadvertent 
instillation of  the wrong solu-
tion, such as hydrogen peroxide 
instead of  multipurpose solutions. 
Manufacturers have attempted to 
address the problem by making the 
bottle tip red, instead of  the cap, 
to identify the hydrogen peroxide 
solution. Red is usually interpreted 
by patients as an alert to potential 
harm and can momentarily stop/
alert the patient to properly read 
the label. This induced moment of  
hesitation can prevent unnecessary 
hydrogen peroxide burns of  the 
corneal and conjunctival surfaces. 
Suggestions for improved 
packaging have included differ-
ent size and shape containers, 
non-interchangeable caps, colour 
coding caps and/or containers, 
child safety caps and Braille warn-
ing on bottles5-11, 16, 17. A different 
bottle cap design for nail adhesive 
has been suggested incorporating a 
child safety feature such as align-
ment of  arrows which would re-
quire good lighting and acuity prior 
to opening.6 In addition to changes 
in packaging and bottle cap design, 
How to prevent eye 
injuries at home; 
accidents due to 
different medicines 
with similar shaped 
containers
Similarities in packaging of eye 
drops and other health & beauty 
products may lead to inadvertent 
ocular injury. Becoming aware 
of some of these similarities may 
prevent potentially harmful eye 
injuries in the home.
Similarities in colour
Contact lens related products from 
different manufacturers may have similar 
packaging but are intended for different 
uses. A careful examination of the bottle 
tip, identified in 
red, is intended 
as a warning for 
the consumer  to 
identify peroxide for 
disinfection and not 




bottle caps can lead 
to inadvertently 
using the wrong 
medication. 
(left: medication for 
glaucoma; right: tear 
lubricant).
Effect of lighting
Crowded shelves of medicine cabinets 
and poor lighting can add to the 
confusion between products. Choose 
products carefully and read the labels in 
good lighting and with proper correction 
(glasses or contact lenses if needed).
Note confusion of white (comfort drops) 
and tan (anti-infective) bottle cap
Patient Education Pamphlet
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patient awareness must be included 
in the overall prevention of  these 
types of  ocular trauma.
Patient education should include 
the segregation of  all ophthalmic 
preparations and CL solutions 
from other health and beauty 
products or other household items. 
Precaution such as carefully  
reading the contents of  the con-
tainer and its intended use in a 
well lit environment with the best 
correction possible could prevent 
injury. Proper patient instruction in 
respecting the coloured bottle cap 
is important in the proper manage-
ment of  the patient’s ocular condi-
tion, especially in the presence of  
more than one ophthalmic medica-
tion. Furthermore, all medication, 
prescribed or over-the-counter, 
should be kept out of  the reach of  
children.
In an attempt to bring further 
awareness to the errors caused by 
similarities in packaging and label-
ing of  ophthalmic medications, 
some organizations have asked for 
people to sign an e-petition on the 
“look alike, sound alike” (LASA) 
issue.18 Hopefully this will bring 
further attention to this issue that 
will ultimately benefit patients’ 
safety in the use of  ophthalmic 
products. A collaborative effort 
including manufacturers, health 
organizations, healthcare providers 
and patients should address  
packaging issues (colour, font size 
for the visually impaired, similari-
ties with other products), safety 
features (caps, expiry dates) and 
establish a quality assurance system 
to assess the effectiveness of  these 
new efforts.
To assist the eye care commu-
nity in bringing further awareness 
to this issue, a patient awareness 
pamphlet has been created en-
titled “Preventing eye injuries in 
the home: Avoiding errors due to 
similarities in appearance”. The 
pamphlet illustrates packaging 
similarities, interchangeable bottle 
caps, similarly coloured caps with 
other health and beauty products 
and the importance of  organizing 
Separate similar colour caps
Although industry standards exist for 
colour coding of bottle caps for eye 
medications, this is not the case for other 
health & beauty products, such as nail 
glue. Separating eye medications will 
prevent inadvertent use of nail glue or 
other products (both in adults and curious 
children).
Organize your cabinet
An ounce of prevention goes a long way. 
Organize your medicine cabinet and 
separate the products intended for the 
eyes from all other products.
Five simple precautions !
1. Use good lighting and proper 
correction when selecting medications.
2. Always read the label to make sure you 
have the correct product.
3. Beware of similarities in packaging, 
bottle size, shape and interchangeable 
caps.
4. Separate your eye medication from all 
other products.
5. Always keep medication, including 
health and beauty products, such as 
nail glue, away from children.
If you have any questions concerning any 
eye care products, check with your eye 
care practitioner.
Your eye care practitioner is:
Created by Etty Bitton, OD, MSc, FAAO
Associate professor 
École d’optométrie, Université de Montréal 







CaNad iaN  JourNal  of  optometr y  |  r eVue  CaNad i eNNe  d ’optométr i eVol 72  |  No 5  OctOber / OctObre 201028
the medicine cabinet to segregate 
ophthalmic products. The pam-
phlet highlights the importance 
of  lighting when reaching for any 
kind of  medication so as to prop-
erly identify the intended container. 
Eye care practitioners can make 
the pamphlets readily available to 
their patients and staff  both in the 
office as a hard copy or electroni-
cally via electronic newsletters or 
as a link on their websites. 
Clinic environments such as 
hospitals, optometry school clinics 
and other multidisciplinary clinics 
have numerous people interacting 
with each other. Bottles of  diag-
nostic medications are usually left 
in examining rooms and vigilance 
amongst workers in replacing the 
appropriate bottle caps and apply-
ing the necessary precaution when 
instilling eye drops of  any kind 
is important to maintain patient 
safety. Interchangeable bottle caps 
render the discrimination of  oph-
thalmic solutions by colour unreli-
able. There is no better universal 
precaution than accurately reading 
the label under proper illumination 
and with an adequate correction 
prior to instillation on the ocular 
surface.
Summary
Ocular injuries with inadvertent 
use of  nail glue due to similarities 
in packaging, bottle size and cap 
design have been reported repeat-
edly in the literature and remain 
a concern for patient safety. This 
case report describes a conjuncti-
val trauma caused by inadvertent 
use of  nail glue and highlights the 
importance of  patient education in 
preventing ocular trauma by seg-
regating ophthalmic preparations. 
Basic precautions such as reading 
the label of  ophthalmic medication 
under proper lighting and with ad-
equate correction coupled with the 
segregation of  ophthalmic prod-
ucts from others in the medicine 
cabinet could have prevented the 
injury. To that end, an awareness 
pamphlet has been created to bring 
further awareness to this issue. 
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